Citigroup’s Quoin Pharmaceuticals QNRX Stock Holding History

Citigroup’s Portfolio QNRX Stock Details QNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2	Closed	-$6K	–	6229
2022 Q2	$6K	Buy	+2	New	+$7.96K	﹤0.01%	5562
2020 Q3	–	Hold	0	–	-$1K	–	7572
2020 Q2	–	Hold	0	–	–	–	7472
2020 Q1	–	Hold	0	–	–	–	7508
2019 Q4	–	Hold	0	–	–	–	7608
2019 Q3	–	Hold	0	–	–	–	7343
2019 Q2	–	Hold	0	–	–	–	7483
2019 Q1	–	Hold	0	–	–	–	7255
2018 Q4	–	Hold	0	–	–	–	6886
2018 Q3	–	Hold	0	–	–	–	6591
2018 Q2	–	Hold	0	–	–	–	6018
2018 Q1	–	Hold	0	–	–	–	6002
2017 Q4	–	Hold	0	–	–	–	5960
2017 Q3	–	Hold	0	–	–	–	5752
2017 Q2	–	Hold	0	–	–	–	6210

Other funds holding QNRX

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup's QNRX Position: Q3 2022 in Review

Citigroup sold out of Quoin Pharmaceuticals (QNRX) in Q3 2022, closing a stake of 2 shares — an estimated $6K sold.

Citigroup first reported a position in QNRX in Q2 2022 and held it in 1 quarter. The position peaked at $6K in Q2 2022. 6 funds tracked by Wall St. Rank hold QNRX as of Q3 2022.

Citigroup reported no remaining Quoin Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Citigroup sold 2 Quoin Pharmaceuticals shares in Q3 2022, an estimated $6K.
Citigroup first reported a position in Quoin Pharmaceuticals in Q2 2022 and held it in 1 quarter.
Citigroup's Quoin Pharmaceuticals position peaked at $6K in Q2 2022.
6 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.